Calcitonin
Calcium-regulating peptide. Bone and calcium-disorder clinical protocols with responsible tracking.
- Half-life
- 30 min
- Out of system
- ~3 h
- Route
- Subcutaneous
- Level
- Advanced
Very short-acting — protocols dose 1–2× a day. After the last dose, roughly 97% has cleared in ~3 h (five half-lives) — the window that matters for washouts, bloodwork and surgery.
What Calcitonin is used for
- Calcium-regulating peptide — lowers blood calcium, slows bone loss
- Older clinical use for osteoporosis and Paget disease
- Has an analgesic effect on certain bone pain
How it's typically used
Clinical range: 200 IU intranasal daily (or 100 IU subcutaneous).
What to watch for
- Long-term use carries a small possible cancer-risk signal
- Nasal form can irritate; nausea/flushing with injection
- Prescription-only; clinician-guided
About Other research compounds
- What they are
- Nootropics, metabolic agents, and research compounds that don't fit the other classes.
- How they're run
- Route and schedule vary widely — check the individual entry.
- What to watch
- This is the least-characterised corner of the atlas. Read the full guide, and treat anything without published human data as exactly that.
Full guide
Calcitonin: A Tracking Guide for a Calcium-Regulating Peptide
What calcitonin is, where it is used clinically for bone and calcium disorders, and how to track a calcitonin protocol responsibly.
Other other research compounds
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.